137 related articles for article (PubMed ID: 35670049)
1. PD-L1 positive lympho-epithelial lesions in inflammatory prostate.
Dikov D; Koleva M; Simitchiev K; Baltov M; Sarafian V
Histol Histopathol; 2022 Aug; 37(8):749-755. PubMed ID: 35670049
[TBL] [Abstract][Full Text] [Related]
2. Strong PD-L1 expression in granulomatous prostatitis.
Dikov D; Koleva M; Mollova A; Fakirova A
Prostate; 2023 Sep; 83(13):1285-1289. PubMed ID: 37357498
[TBL] [Abstract][Full Text] [Related]
3. Histopathology of nonspecific granulomatous prostatitis with special reference to eosinophilic epithelial metaplasia: Pathophysiologic, diagnostic and differential diagnostic correlations.
Dikov DI; Koleva MS; Boivin JF; Lisner T; Belovezhdov VT; Sarafian V
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S34-S40. PubMed ID: 32108624
[TBL] [Abstract][Full Text] [Related]
4. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
Dikov D; Bachurska S; Staikov D; Sarafian V
Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
7. Nonspecific granulomatous prostatitis in association with eosinophilic epithelial metaplasia and prostatic adenocarcinoma.
Dikov DI; Koleva MS; Peshev ZK; Belovezhdov VT
Indian J Pathol Microbiol; 2017; 60(3):409-411. PubMed ID: 28937384
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic metaplasia in transurethral resection of the prostate.
Koleva MS; Dikov DI; Belovezhdov VT; Sarafian V
Indian J Pathol Microbiol; 2020; 63(3):423-426. PubMed ID: 32769332
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
10. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
11. Association between asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification in patients with obstructive benign prostatic hyperplasia.
Engelhardt PF; Seklehner S; Brustmann H; Riedl CR; Lusuardi L
Minerva Urol Nefrol; 2016 Jun; 68(3):242-9. PubMed ID: 26013949
[TBL] [Abstract][Full Text] [Related]
12. Can expressed prostatic secretions effect prostate biopsy decision of urologist?
Ergun O; Capar E; Goger YE; Ergun AG
Int Braz J Urol; 2019; 45(2):246-252. PubMed ID: 30648827
[TBL] [Abstract][Full Text] [Related]
13. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
17. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific (idiopathic) granulomatous prostatitis associated with low-grade prostatic adenocarcinoma.
Val-Bernal JF; Zaldumbide L; Garijo MF; González-Vela MC
Ann Diagn Pathol; 2004 Aug; 8(4):242-6. PubMed ID: 15290678
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.
Nickel JC; Downey J; Young I; Boag S
BJU Int; 1999 Dec; 84(9):976-81. PubMed ID: 10571623
[TBL] [Abstract][Full Text] [Related]
20. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
Zhang F; Si-Mu-Jiang-Abula A; Zhang LD
Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
